04623nam 2200553 450 991079079140332120230725061935.01-60795-216-5(CKB)2550000001146680(EBL)3386948(MiAaPQ)EBC3386948(Au-PeEL)EBL3386948(CaPaEBR)ebr10949541(OCoLC)923336891(EXLCZ)99255000000114668020141016h20112011 uy 0engur|n|---|||||rdacontentrdamediardacarrierAdvanced therapy of inflammatory bowel diseaseVolume 1IBD and ulcerative colitics /Theodore M. Bayless, Stephen B. Hanauer ; editor, Linda Mehta ; cover designer, Mary McKeonThird edition.Shelton, Connecticut :People's Medical Publishing House,2011.©20111 online resource (648 p.)Description based upon print version of record.1-60795-034-0 Includes bibliographical references and index at the end of each chapters.""Advanced Therapy of IBD: Ulcerative Colitis (Volume 1) ""; ""Contents ""; ""Contributors ""; ""Preface ""; ""Acknowledgments ""; ""Tribute ""; ""Part I: Introduction ""; ""1: Expectations for the Patient with Ulcerative Colitis ""; ""2: Expectations for the Patient with Crohn's Disease ""; ""3: Living with Ulcerative Colitis ""; ""4: Living with Crohn's Disease ""; ""5: Interactions among the Pediatric Patient, His or Her Family, and the Doctor ""; ""6: Dealing with Teens with IBD ""; ""7: Psychosocial Concomitants of Pediatric IBD ""; ""8: Recognizing and Managing Patients Concerns """"9: Benefits of Enhancing the Patient-Medical Professional Interface """"Part II: Etiology and Pathophysiology of IBD ""; ""10: IBD Pathogenesis: Current Concepts ""; ""11: IBD Genetics: Potential Clinical Relevance ""; ""12: Effect of Age of Onset on IBD Phenotypes and Genotypes ""; ""13: Environmental Influences in IBD ""; ""14: Biological Therapy in IBD ""; ""15: Addressable Pathophysiologic Alterations in the IBD Patient ""; ""16: Molecular Mechanisms of Colitis-Induced Cancer ""; ""Part III: Diagnostic/Prognostic Methodology ""; ""17: Clinical Subtypes in IBD """"18: Computer Database for Patients with IBD """"19: Clinical Measures of Disease Activity ""; ""20: Useful Biological Markers as Activity Indices ""; ""21: The Role of Genetics and Serology in Diagnosing and Predicting the Natural History of IBD ""; ""22: Pediatric IBD: Presentations and Diagnosis, Including Serologies ""; ""23: Clinical Utility of Quallity of Life Measurements ""; ""24: Endoscopy in IBD ""; ""25: Magnifying Colonoscopy in IBD Patients ""; ""26: Endoscopic Biopsies ""; ""27: Crohn's Disease: CT Scanning in Clinical Decision Making """"28: CT Enterography and Other Small Bowel Imaging """"29: Imaging IBD with FDG PET and PET/CT ""; ""30: Video Capsule Endoscopy and IBD ""; ""31: Transabdominal Bowel Sonography in Clinical Decision Making ""; ""32: Imaging Options in Perianal Crohn's Disease ""; ""Part IV: Aggravating Factors in IBD ""; ""33: IBD and Stress ""; ""34: ""Refractory"" IBD - A Misnomer? ""; ""35: Infectious Agents as Aggravating Factors in IBD ""; ""36: Viral Infections in IBD ""; ""37: Clostridium difficile and IBD ""; ""38: Nonsteroidal Anti-Inflammatory Drugs and IBD ""; ""39: Smoking and Crohn's Disease """"40: Reducing Dietary Symptoms in Irritable Bowel Syndrome and IBD """"41: Coexisting Irritable Bowel Syndrome and IBD ""; ""42: Managing Irritable Bowel Syndrome and IBD in the Same Individual ""; ""43: Adverse Influences of Pregnancy on IBD ""; ""Part V: Medical Therapy of IBD ""; ""44: Pharmacogenomics in IBD ""; ""45: The Placebo Response in IBD ""; ""46: Adherence Issues in the Management of IBD ""; ""47: Emerging Therapeutic Strategies for the Treatment of IBD: Mechanisms & Challenges """"48: The Luminal Contents in IBD: What Clinicians Should Know About the Microbiota and its Manipulation ""Inflammatory bowel diseasesInflammatory bowel diseases.616.3/44Bayless Theodore M.1931-1446588Hanauer Stephen B.Mehta LindaMcKeon MaryMiAaPQMiAaPQMiAaPQBOOK9910790791403321Advanced therapy of inflammatory bowel disease3779227UNINA